BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22613796)

  • 21. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
    Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
    BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutting Edge: Epitope-dependent effect of Nef-mediated HLA class I down-regulation on ability of HIV-1-specific CTLs to suppress HIV-1 replication.
    Tomiyama H; Fujiwara M; Oka S; Takiguchi M
    J Immunol; 2005 Jan; 174(1):36-40. PubMed ID: 15611225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Specific immune responses to human immunodeficiency virus type 1 Gag, Tat, Rev and Nef proteins].
    Zhai S; Kang WZ; Yu X; Wang SY; Walker BD; Altfeld M; Sun YT
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):175-9. PubMed ID: 15766402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CTL-mediated selective pressure influences dynamic evolution and pathogenic functions of HIV-1 Nef.
    Ueno T; Motozono C; Dohki S; Mwimanzi P; Rauch S; Fackler OT; Oka S; Takiguchi M
    J Immunol; 2008 Jan; 180(2):1107-16. PubMed ID: 18178851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
    Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
    AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection and accumulation of an HIV-1 escape mutant by three types of HIV-1-specific cytotoxic T lymphocytes recognizing wild-type and/or escape mutant epitopes.
    Akahoshi T; Chikata T; Tamura Y; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2012 Feb; 86(4):1971-81. PubMed ID: 22156528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune selection in vitro reveals human immunodeficiency virus type 1 Nef sequence motifs important for its immune evasion function in vivo.
    Lewis MJ; Lee P; Ng HL; Yang OO
    J Virol; 2012 Jul; 86(13):7126-35. PubMed ID: 22553319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A robust and scalable TCR-based reporter cell assay to measure HIV-1 Nef-mediated T cell immune evasion.
    Anmole G; Kuang XT; Toyoda M; Martin E; Shahid A; Le AQ; Markle T; Baraki B; Jones RB; Ostrowski MA; Ueno T; Brumme ZL; Brockman MA
    J Immunol Methods; 2015 Nov; 426():104-13. PubMed ID: 26319395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of HLA-B*5401-restricted HIV-1-Nef and Pol-specific CTL epitopes.
    Kitano M; Kobayashi N; Kawashima Y; Akahoshi T; Nokihara K; Oka S; Takighuchi M
    Microbes Infect; 2008 Jun; 10(7):764-72. PubMed ID: 18538615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL.
    Yang OO; Sarkis PT; Trocha A; Kalams SA; Johnson RP; Walker BD
    J Immunol; 2003 Oct; 171(7):3718-24. PubMed ID: 14500671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.
    Zou C; Murakoshi H; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.
    Tomiyama H; Akari H; Adachi A; Takiguchi M
    J Virol; 2002 Aug; 76(15):7535-43. PubMed ID: 12097566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A conserved HLA B13-restricted cytotoxic T lymphocyte epitope in Nef is a dominant epitope in HLA B13-positive HIV-1-infected patients.
    Harrer EG; Bergmann S; Eismann K; Rittmaier M; Goldwich A; Müller SM; Spriewald BM; Harrer T
    AIDS; 2005 Apr; 19(7):734-5. PubMed ID: 15821402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.
    Karlsson AC; Iversen AK; Chapman JM; de Oliviera T; Spotts G; McMichael AJ; Davenport MP; Hecht FM; Nixon DF
    PLoS One; 2007 Feb; 2(2):e225. PubMed ID: 17311088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structured observations reveal slow HIV-1 CTL escape.
    Roberts HE; Hurst J; Robinson N; Brown H; Flanagan P; Vass L; Fidler S; Weber J; Babiker A; Phillips RE; McLean AR; Frater J;
    PLoS Genet; 2015 Feb; 11(2):e1004914. PubMed ID: 25642847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of naturally-arising HIV Nef mutations on cytotoxic T lymphocyte recognition and Nef's functionality in primary macrophages.
    Mwimanzi P; Hasan Z; Hassan R; Suzu S; Takiguchi M; Ueno T
    Retrovirology; 2011 Jun; 8():50. PubMed ID: 21696586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
    Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes.
    Almeida CA; Bronke C; Roberts SG; McKinnon E; Keane NM; Chopra A; Kadie C; Carlson J; Haas DW; Riddler SA; Haubrich R; Heckerman D; Mallal S; John M
    J Immunol; 2011 Sep; 187(5):2502-13. PubMed ID: 21821798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.
    Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD
    J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.